Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001152 · ClinicalTrials.gov registry record
Pigment Dispersion Syndrome With and Without Glaucoma
A clinical trial of Glaucoma and Ocular Hypertension, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 175
- Enrollment target
- 1
- Study location
NCT00001152: Completed study of Glaucoma and Ocular Hypertension, sponsored by National Eye Institute (NEI).
NCT00001152 is a study of Glaucoma and Ocular Hypertension that has completed, run by National Eye Institute (NEI). The registered enrollment target is 175 participants, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001152, a study of Glaucoma and Ocular Hypertension, has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare patients having PDS without and with OH or GL by documenting and following the clinical features and course of their disease and evaluating the patient's performance on a variety of diagnostic tests.
Conditions Studied
Study Locations (1)
Maryland
- National Eye Institute (NEI) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 1976-06 |
| Est. Completion | 2000-06 |
What the finished NCT00001152 record still lists
NCT00001152 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 909-participant average among 92 other Glaucoma trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Glaucoma appearing as the primary indexed condition, and to 0 interventions.
NCT00001152 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001152 about?
NCT00001152 is a clinical study titled "Pigment Dispersion Syndrome With and Without Glaucoma". To compare patients having PDS without and with OH or GL by documenting and following the clinical features and course of their disease and evaluating the patient's performance on a variety of diagnostic tests.
What is the current status of trial NCT00001152?
This trial is currently completed. The enrollment target is 175 participants. The study started on 1976-06. Estimated completion is 2000-06.
What conditions does trial NCT00001152 study?
This clinical trial studies the following conditions: Glaucoma, Ocular Hypertension, Glaucoma Open-Angle.
Who is sponsoring clinical trial NCT00001152?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001152 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001152's enrollment target sits among peer trials
175 29th of 92 higher than 64 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia